Entest Group Inc

[JokersWild12]

That's an older video but Entest(ENTB) is pursuing a different therapy approach now and IMO in a much better position than ever to succeed with drugs that treat canine and feline cancer and arthritis with their approach with NR2F6 that is leveraged with developments at Regen. The science shows that it works.

Pre-clinical research indicates that by inhibiting NR2F6, cancer stem cells can be converted into normal cells, thus potentially curing the patient(animal/human) of cancer. Additionally, activators of NR2F6 have the potential to provide relief from autoimmune diseases such as arthritis in both animals and humans.

Most recently in October 2016 Entest filed a composition of matter patent for Small Molecule Modulators of NR2F6 Activity for Animals.

2017 should be an interesting year for ENTB. I am waiting to see the plans and activities, new website, added management, science board that was mentioned in the 12/21/16 press release which we were told is all coming soon. Along with visibility to tracking ENTB progress.

IMO. GL and Happy New Year!